ArticleJournal of neuroinflammation2018

Anti-CD52 antibody treatment depletes B cell aggregates in the central nervous system in a mouse model of multiple sclerosis.

Micha Simon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.